| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/09/1998 | EP0862454A1 Novel uses of mammalian ctla-8 and related reagents |
| 09/09/1998 | EP0862450A2 A method for inhibiting attachment of h. influenzae to human cells using phosphorylated recombinant human beta-casein |
| 09/09/1998 | EP0862448A1 Fine tuned protegrins |
| 09/09/1998 | EP0862435A1 Inhibitors of farnesyl-protein transferase |
| 09/09/1998 | EP0862432A1 Two-photon upconverting dyes and applications |
| 09/09/1998 | EP0862431A1 Pharmaceutical formulation |
| 09/09/1998 | EP0862430A1 Anti-viral compounds |
| 09/09/1998 | EP0630368B1 Antiviral nucleoside analogues |
| 09/09/1998 | EP0584085B1 Antibiotic carbapenem derivatives |
| 09/09/1998 | EP0573527B1 Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e. coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e. coli bacteria in humans |
| 09/09/1998 | EP0513200B1 Method and compositions for the synthesis of bch-189 and related compounds |
| 09/09/1998 | EP0454813B1 A casein fraction for therapeutic, prophylactic and/or diagnostic use in infections of the respiratory tract |
| 09/09/1998 | CN1192783A Marek's disease virus genes and their use in vaccines for protection against marek's disease |
| 09/09/1998 | CN1192750A Cyclosporin derivatives with anti-HIV effect |
| 09/09/1998 | CN1192740A Novel camptothecin analogues, prepn. method therefor, use thereof, and pharmaceutical compositions contg. same |
| 09/09/1998 | CN1192695A High affinity human monoclonal antibodies specific for RSV F-protein |
| 09/09/1998 | CN1192694A Vector for diagnosis and treatment of solid tumors including melanoma |
| 09/09/1998 | CN1192688A Treatment of HIV and other viral infections using combinatory therapy |
| 09/09/1998 | CN1192687A Bacterial inhibition with an oligosaccharide compound |
| 09/09/1998 | CN1192684A Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections |
| 09/09/1998 | CN1192440A The intermediates diaza or oxadiazabicyclic compounds |
| 09/09/1998 | CN1192376A Compound interferon antiviral drug, prepn. and use thereof |
| 09/08/1998 | US5804599 Oxabicyclo(4.1.0)heptane derivatives; antibacterial agents |
| 09/08/1998 | US5804577 Cephalosporin derivatives |
| 09/08/1998 | US5804571 Administering an s-omega(omega-aminoalkylamino)alkyl dihydrogen phosphorothioate |
| 09/08/1998 | US5804565 Antibiotic effective against haemophilus influenzae |
| 09/08/1998 | US5804559 Prodrug derivatives of enzyme inhibitors having hydroxyl groups, a process for preparing them, and their use |
| 09/08/1998 | US5804558 Containing disulfide bonds; useful as preservatives and in preventing, treating or ameliorating viral or microbial infections in animals and plants |
| 09/08/1998 | US5804552 Compound consisting of tyrosine or hydroxyproline linked to phospholipid by phosphoester bond through hydroxyl group; capable of conjugation with therapeutic peptide |
| 09/08/1998 | US5804549 Glycerol monolaurate, nisin in the absence of a chelator and a carrier |
| 09/08/1998 | US5804440 A deoxypolynucleotide encoding heavy chanin immunologlobulin variable region amino acid residue sequence portion of humans monoclonal antibody which is used in immunotherapy and diagnosis |
| 09/08/1998 | US5804413 Herpes simplex virus strains for gene transfer |
| 09/08/1998 | US5804399 Incubation; measuring effect of composition on kinase or polynucleotide encoding the kinase |
| 09/08/1998 | US5804378 Test kit including primers for amplification, reagents for hybridization |
| 09/08/1998 | US5804199 Oil-based and water-based adjuvant mixture |
| 09/08/1998 | US5804198 Vaccines against disease caused by pathogenic pilus-forming bacteria |
| 09/08/1998 | US5804197 Recombinant canine herpesviruses |
| 09/08/1998 | US5804194 Immunophrophylaxis by deletion of a gene encoding a protein produced in response to environmental stress; treatment of food poisoning, typhoid, salmonellosis in pigs |
| 09/08/1998 | US5804190 Recombinant vaccine for porcine pleuropneumonia |
| 09/05/1998 | CA2230965A1 New benzoxazinedione derivatives, a method of producing them and the use thereof |
| 09/03/1998 | WO1998038320A1 Component of bromelain |
| 09/03/1998 | WO1998038319A1 Component of bromelain |
| 09/03/1998 | WO1998038312A1 Bacterial elastin binding protein, nucleic acid sequence encoding same and diagnostic and therapeutic methods of use thereof |
| 09/03/1998 | WO1998038291A1 Component of bromelain |
| 09/03/1998 | WO1998038212A2 Chimeric polypeptides containing chemokine domains |
| 09/03/1998 | WO1998038199A1 Novel erythromycin derivatives, method of preparation and application as medicines |
| 09/03/1998 | WO1998038193A1 Method for the preparation of (+)-calanolide a and analogues thereof |
| 09/03/1998 | WO1998038170A1 Substituted benzimidazoles and their use for treating retroviral infection |
| 09/03/1998 | WO1998038163A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | WO1998037918A1 Staphylococcus 3-dehydroquinate synthase |
| 09/03/1998 | WO1998037912A1 A new composite vaccine which contains antigen, antibody and recombinant dna and its preparing method |
| 09/03/1998 | WO1998037911A1 Chimeric flavivirus vaccines |
| 09/03/1998 | WO1998037891A1 Antimicrobial agent for agriculture |
| 09/03/1998 | WO1998037890A1 Antimicrobial agent |
| 09/03/1998 | WO1998037877A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | WO1998028317A3 Synthesis of nucleosides and polynucleotides |
| 09/03/1998 | WO1998024910A3 Mutants of streptococcal toxin c and methods of use |
| 09/03/1998 | WO1998024397A3 Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense |
| 09/03/1998 | CA2282656A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | CA2282655A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | CA2282552A1 Substituted benzimidazoles and their use for treating retroviral infection |
| 09/03/1998 | CA2281582A1 Antimicrobial agent |
| 09/03/1998 | CA2247072A1 Bacterial elastin binding protein, nucleic acid sequence encoding same and diagnostic and therapeutic methods of use thereof |
| 09/02/1998 | EP0861899A1 LicA polypeptides from Sreptococcus pneumoniae |
| 09/02/1998 | EP0861892A1 Stress protein epitopes |
| 09/02/1998 | EP0861890A1 LicC polypeptides from Streptococcus pneumoniae |
| 09/02/1998 | EP0861889A1 LicD2 polypeptides from Streptococcus pneumoniae |
| 09/02/1998 | EP0861850A1 Tumor necrosis related receptor, TR4 |
| 09/02/1998 | EP0861665A1 Infectious bursitis vaccine |
| 09/02/1998 | EP0861659A1 Sustained release drug delivery devices |
| 09/02/1998 | EP0861322A1 Antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for replication |
| 09/02/1998 | EP0861321A2 Phosphopantetheinyl transferases and uses thereof |
| 09/02/1998 | EP0861255A1 Hemoregulatory compounds |
| 09/02/1998 | EP0861254A1 Hemoregulatory compounds |
| 09/02/1998 | EP0861249A1 Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 09/02/1998 | EP0861235A1 Substituted benzylaminopiperidine compounds |
| 09/02/1998 | EP0861091A1 Immunotoxin containing a disulfide-stabilized antibody fragment |
| 09/02/1998 | EP0861085A1 Anti-viral isolates obtainable from leeches |
| 09/02/1998 | EP0861080A1 Hemoregulatory compounds |
| 09/02/1998 | EP0861078A1 Hemoregulatory compounds |
| 09/02/1998 | EP0861077A1 Hemoregulatory compounds |
| 09/02/1998 | EP0861076A1 Hemoregulatory compounds |
| 09/02/1998 | EP0861074A1 Non-ionic surfactant vesicles as therapeutic agent |
| 09/02/1998 | EP0861071A1 Benzamidoxime prodrugs as antipneumocystic agents |
| 09/02/1998 | EP0861032A1 Aquatic animal treatment method and composition containing cajeput oil |
| 09/02/1998 | EP0861030A1 Hemoregulatory compounds |
| 09/02/1998 | EP0861029A1 Hemoregulatory compounds |
| 09/02/1998 | EP0861027A1 IceA GENE AND RELATED METHODS |
| 09/02/1998 | EP0636173B1 Treatment of hiv-associated immune thrombocytopenic purpura |
| 09/02/1998 | EP0606217B1 Ctl4a receptor, fusion proteins containing it and uses thereof |
| 09/02/1998 | EP0594610B1 PROTEIN D - AN IgD-BINDING PROTEIN OF HAEMOPHILUS INFLUENZAE |
| 09/02/1998 | EP0426785B1 Compositions and methods for treating viral infections |
| 09/02/1998 | CN1192241A Streptococcal heat shock proteins members of the HSP70 family |
| 09/02/1998 | CN1192240A Recombinant mistletoe lectin (rML) |
| 09/02/1998 | CN1192219A Reversible cysteine protease inhibitors |
| 09/02/1998 | CN1192216A Substituted liposaccharides useful in the treatment and prevention of endotoxemia |
| 09/02/1998 | CN1192147A Imidazole compounds |
| 09/02/1998 | CN1192146A 4,4-(disubstituted) cyclohexan-1-ols)-monomers and related compounds |
| 09/02/1998 | CN1192138A Acyclovir derivatives for topical use |
| 09/02/1998 | CN1191898A Self-enhancing, pharmacologically controllable expression systems |